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We previously described a 27-amino acid peptide 
neurotoxin from the venom of Conus geographus, w-
conotoxin GVIA, which inhibits neuronal voltage-ac-
tivated calcium channels. In this paper we describe the 
total synthesis of w-conotoxin GVIA and demonstrate 
that it efficiently blocks voltage-activated uptake of 
41!Ca by standard synaptosomal preparations from 
chick brain. Dihydropyridines do not block 41!Ca up-
take under these conditions. Thus, the w-conotoxin-
sensitive, but dihydropyridine-insensitive uptake of 
41iCa2+ by chick brain synaptosomes serves as a func-
tional assay for a Ca channel target of w-conotoxin. 
The use of synthetic GVIA should rapidly accelerate 
our understanding of the molecular biology of Ca2+ 
channels and their role in neuronal function. 
Voltage-sensitive calcium channels are critical components 
of neurons. Their role in neurotransmitter release is well 
established (1, 2). In addition electrophysiological work has 
indicated that calcium channels are essential for the genera-
tion of the complex firing patterns that are found in certain 
neurons (see for example Ref. 3). For this reason a biochemical 
characterization of calcium channels in neuronal tissue should 
be an important step toward understanding neuronal function 
at the molecular level. 
To this point the major probes used for studying neuronal 
calcium channels have been the dihydropyridines (4, 5), and 
a large number of studies have been carried out using these 
agents. However, although the dihydropyridines have well-
defined effects on voltage-sensitive Ca2+ channels in muscle, 
their effects on neuronal tissue have been complex, and the 
interpretation of the observed effects has been controversial. 
Recently, we described a new neurotoxin probe for neuronal 
calcium channels, w-conotoxin GVIA from the venom of the 
fish-hunting cone snail, Conus geographus (6, 7). This 27-
amin,o acid peptide (Fig. 1) has been shown to block neuronal 
calcium channels in a variety of preparations (8) .1,2 However, 
the use of this promising agent for biochemical studies has 
been hampered by two factors. First, the availability of the 
toxin has been very limited because it has to be purified from 
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the venom of rather small snails, Second, although we have 
developed a binding assay for w-conotoxin GVIA (11), func-
tional assays for its effects on voltage-activated calcium cur-
rents in neuronal tissue have been confined to electrophysio-
logical methods which measure the response of only one cell 
or a small group of cells. There has been no convenient way 
to assess w-conotoxin effects on Ca2+ channel activity in the 
same preparations in which w-conotoxin binding is assayed. 
The results reported in this communication should alleviate 
these problems. First, the chemical synthesis of w-conotoxin 
GVIA is described, creating much more substantial amounts 
oftoxin for biochemical studies. Second, we demonstrate that 
w-conotoxin GVIA inhibits voltage-dependent uptake of 45Ca 
by chick brain synaptosomes prepared by standard methods. 
Under the same conditions, the dihydropyridines do not in-
hibit. 
EXPERIMENTAL PROCEDURES 
Syntlu!sis of w-Conotoxin GVIA-All t-butyloxycarbonyl amino 
acids were of the L·configuration except for t-butyloxycarbonyl-Gly 
and were purchased from BACHEM, Torrance, CA. t·Butyloxycar-
bonyl amino acids included: (S-paramethoxybenzyl), Lys (2-chloro-
benzyloxycarbonyl), Ser (O-benzy!), Hyp (O·benzyl), Thr (O-benzyl), 
Tyr (2-bromobenzyloxycarbonyl) and Arg (Tosy!). Asparagine was 
incorporated into the peptide with an unprotected side chain. Step· 
wise buildup of the peptide on paramethylbenzhydrylamine resin (12) 
(4 g:0.43 meqjg) was done automatically on a Beckman S90B syn-
thesizer using previously reported protocols (13) and 1.25 eq of 
protected amino acid/g of resin. Trifluoroacetic acid (60% in CH2Cl2 
+ 2% ethanedithiol) was utilized for deblocking; triethylamine (10% 
in CH2CI2) was used for neutralization; resin washing was accom-
plished by application of isopropyl alcohol (1 % ethanedithiol) after 
trifluoroacetic acid treatment, and by methanol or dichloromethane 
at the other steps. Couplings (100-140 min) were mediated by diiso· 
propylcarbodiimide in either dichloromethane, dimethylformamide, 
or mixtures thereof depending upon the solubility of the respective 
amino acid derivatives. t-Butyloxycarbonyl-Asparagine, as previously 
noted, was coupled unprotected in dimethylformamide in the presence 
of 2 eq of 1-hydroxybenzotriazole. Recouplings were automatically 
performed at ArfS,17, Lys", Hyp21, Asn20•14, Cys'6, and Ser'l·3. A final 
peptide resin (11.2 g) was obtained. The peptide was released from 
the peptide resin (4.0 g) as the COOH·terminal amide by treatment 
with distilled anhydrous HF (75 ml) in the presence of p-cresol (10 
g) at 0 'C for 30 min. After removal ofthe HF under reduced pressure, 
the resin was washed portionwise with 300 ml of diethyl ether. The 
peptide was quickly extracted from the resin with distilled water and 
diluted to 3.5 liters with chilled distilled water. The solution was 
adjusted to pH 7 with NH.OH, and allowed to slowly stir and air 
oxidize at 4 ' C for 2 days. The peptide solution, which initially gave 
a positive Ellman test with 5,5' -dithiobis-(2-nitrobenzoic acid), at 
this point showed no evidence of free sulfhydryl groups. After acidi-
fication of the solution to pH 5 with acetic acid, the peptide was 
concentrated by passage through a column containing approximately 
75 ml of Bio-Had Bio·Rex-70 cation exchange resin (H+ form). After 
extensive washing with distilled H20 (300 m!) and 5% aqueous acetic 
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TABLE I 
Charcu:terization of conotoxin GVIA 
HPLC analysis· 
[alD" Solvent system Flow rate Gradient Retention % purity volume A B 
ml/min ml 
-18.4 ·C TEAP 2.25 30% CH3CN; 70% A 2 20% B (20 min) - 40% B 27.0 >98 
0.1 % Trifluoro- 30% CHaCN in 2 36% B (20 min) - 56% B 32.2 >98 
acetic acid 0.1% TFA 
a C = 0.5; 1% HOAc; 20 ·C. 
b UV monitoring was done at 210 nm. 0.2 absorbance units at full scale. Column was Vydac (0.46 X 25 em) 
packed with CIS, 5-"m particles, 300 A pore size. 
acid (300 ml), the peptide was removed from the resin by the addition 
of 50% aqueous acetic acid (300 ml). The peptide solution was 
concentrated to a pale oil on a rotary evaporator and immediately 
taken up in distilled H20, shell frozen, and lyophilized to a white 
powder (yield, 930 mg). The crude peptide was purified using prepar-
ative HPLC' techniques as previously described (14); the gradient of 
acetonitrile applied to the preparative cartridge in TEAP-2.25 was 0-
15% in 1 h, with a flow rate of 100 ml/min. Analysis ofthe generated 
fractions was achieved using isocratic conditions (15% acetonitrile in 
0.1% trifluoroacetic acid) on a 5-"m Vydac CIS column. Desalting was 
carried out using an acetonitrile gradient from 0 to 25% in 0.1% 
trifluoroacetic in 45 min. Highly purified fractions were pooled and 
lyophilized yielding conotoxin G-VIA as the trifluoroacetate (25.6 
mg). Results of the HPLC analysis of this fraction are given in Table 
I along with the optical rotation in 1 % AcOH. Amino acid analysis 
gave the following ratios with expected values in parentheses: Asp 
(2), 2.61 including presence of Hyp (3); Thr (2), 1.91; Ser (6), 5.62; 
Gly (1), 1.00; Cys (6), 5.56; Tyr (3),3.04; Lys (2), 2.02; Arg (2), 2.20. 
FAB Mass Spectrometry-Positive ion FAB mass spectra were 
taken with a Jeol HX-loo HF double-focusing mass spectrometer 
operating at 5 kV accelerating potential and using a 3 kV xenon atom 
beam (cam). 1-10 nmol of peptide were dissolved in -1 "I of 5% 
aqueous HOAc and 1 ILl of glycerol on a 1.5 x 6-mm stainless steel 
sample stage. Spectral data were collected and mass assigned using a 
Jeol DA5000 data system. Mass assignments are accurate to ±0.2 
atomic mass unit. The spectrum showed a protonated molecular ion 
(MH+) at mJ z = 3036.0, corresponding to the calculated monoisotopic 
fully oxidized peptide amide of 3036.2. 
Sequence Verification-A sample of peptide was reduced and car-
boxymethylated, and analyzed for 27 cycles of degradation in a 
Beckman 890D sequencer, as previously described (6). 
A second synthetic strategy using the acetamidomethyl protecting 
group for cysteine was also successful. Synthesis proceeded essentially 
as described above. The linear acetamidomethyl-Cys protected pep-
tide was obtained after HF cleavage and was purified using prepara-
tive HPLC. Amino acid analysis of this material gave the expected 
ratios. Removal of the acetamidomethyl protecting group was 
achieved using Hg(OAc)2 and previously reported protocols (15). 
Cyclization using air oxidation was carried out as described above. 
Purification by semipreparative HPLC yielded the desired product. 
Because yields of purified material were not significantly different 
from that obtained in our first protocol using S-paramethoxybenzyl 
Cys, which is considerably simpler, we favor the former synthetic 
scheme for the synthesis of GVIA. 
Biological Assay-Intracerebral injection of 11-14 g mice with w-
conotoxin resulted in a persistent tremor as described previously (6). 
At low doses (1-2 nmol/kg)., mild tremors could be induced by holding 
mice by their tails and rotating slowly ("tail test"). 
Preparation of Synaptosomes-The method used was based on that 
described by Krueger et at. (16). Unless otherwise specified, all cen-
trifugation was for 1 min using an Eppendorf 5412 centrifuge at 
15,000 rpm (15,600 X g). In a typical preparation of synaptosomes to 
be used in calcium uptake experiments, 18 brains were removed from 
2-day-old chicks and homogenized in 80 ml of ice-cold 0.32 M sucrose, 
0.5 mM HEPES, pH 7.4 using a glass-Teflon homogenizer (clearance 
3 The abbreviations used are: HPLC, high pressure liquid chro-
matography; HEPES, 4-(2-hydroxyethyl) -l-piperazineethanesuifonic 
acid; S-saline; synaptosomal saline; EGTA, [ethylenebis(oxyeth-
ylenenitrilo»)tetraacetic acid; TEAP, triethylammonium phosphate. 
0.175 mm) at 850 rpm (12 strokes). The homogenate was centrifuged 
at 3600 rpm for 10 min in a SorvaH SS-34 rotor. The supernatant 
was retained, and the peHet was resuspended in 40 ml of buffered 
0.32 M sucrose and homogenized with 4 strokes. The supernatants 
were combined and centrifuged at 3600 rpm for 10 min and the pellet 
was discarded. The supernatant was then centrifuged at 12,500 rpm 
for 20 min, retaining the pellet. A dense clump of mitochondria had 
sedimented to the bottom of the tube; the looser pellet above this 
layer was carefully scraped off, and was then suspended in 40 ml of 
buffered 0.32 M sucrose and centrifuged at 12,500 rpm for 20 min. 
The supernatant was discarded. The pellet was resuspended in 30 ml 
of buffered 0.32 M sucrose. Aliquots (10 ml) were layered onto 20 ml 
0.8 M sucrose, 5 mM Na HEPES, pH 7.4. Additional buffered 0.32 M 
sucrose was layered to fill the tube. The tubes were centrifuged at 
8,300 rpm in a SW 27 swinging bucket rotor for 30 min. The 0.32 M 
sucrose layer and the interface were discarded. The 0.8 M layer was 
saved and the peHet was discarded. To the 0.8 M layer, approximately 
700 ml of synaptosomal saline (S-saline) (145 mM NaCI, 5 mM KCI, 
1.4 mM MgCI., 1.2 mM NaH2PO., 10 mM glucose, and 20 mM Tris-
HEPES, pH 7.4) was added in 1-5-ml portions over a period of 20 
min. The mixture was centrifuged at 8,000 rpm in a GSA rotor for 8 
min. The pellets were combined and resuspended in 55 ml of S-saline. 
Aliquots (0.5 m!) of this preparation were centrifuged, and the pellets 
were used for individual reactions. 
"Ca Uptake-The method used was based on that of Blaustein 
(17). To the synaptosomal peHet above, 45 "I of either toxin, dihydro-
pyridine, or control buffer (S-saline + 0.2 mgJmllysozyme) was added; 
the mixture was then completely resuspended and kept on ice for 30 
min. An S-saline solution containing 10 mM CaCl2 (5 ,,1) was added, 
the mixture was vortexed and incubated for 15 min at 30 ·C. At the 
end of this incubation, 0.1 ml of either low potassium "Ca (0.2 mCiJ 
ml "Ca dissolved in S-saline + 1 mM CaCI.) or high potassium "Ca 
(0.2 mCi/ml t6Ca in S-saline + 1 mM CaCI2, with 137 mM KCl 
replacing NaC!) solution was added. After 1 s of incubation, the 
reaction was terminated by adding 0.05 ml of an EGTA solution (120 
mM NaCI, 5 mM KCI, 30 mM EGTA-Tris, pH 7.6) foHowed by 0.6 ml 
of S-saline. The reaction mixture was centrifuged, the supernatant 
aspirated, and 0.8 ml of sodium wash (S-saline + 1 mM CaCl2 without 
glucose or NaH.PO.) added to the pellet (without mixing). The 
supernatant was aspirated, and the pellet was resuspended in 0.8 ml 
of sodium wash with vigorous mixing. The mixture was recentrifuged 
and the sodium wash was repeated. After one more centrifugation, 
the supernatant was aspirated, and the pellet was resuspended in 0.4 
ml of 1 N sodium hydroxide and incubated for 8 min at 68 ·C. After 
vigorous mixing, it was incubated for an additional 8 min, foHowed 
by centrifugation. In order to determine radioactivity in the solutions, 
0.066 ml of the sodium hydroxide mixture was added to 0.1 mlofO.67 
N HCI containing 2 mM calcium chloride and 4 ml of aquasol scintil-
lation fluid. 
In some preliminary experiments with crude synaptosomal frac-
tions, filtration was used with results qualitatively similar to the 
centrifugation assay. A number of uptake experiments were also 
performed in S-saline in which N aCI was replaced by choline chloride; 
however, in this medium, depolarization-induced 45Ca uptake by the 
chick brain synaptosomes was lower «50%) than under the standard 
conditions above. 
RESULTS 
Synthesis of w-Conotoxin GVIA-The synthesis of w-cono-
toxin G VIA was carried out as described under "Experimental 
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FIG. 1. Sequence of w-conotoxin GVIA (from Olivera et aI. 
(6». 
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FIG. 2. HPLC comparison of synthetic and natural w-cono-
toxin GVIA. Synthetic and natural w-conotoxin GVIA (-1 nmol 
each), 88 well as an equimolar mixture (-0.45 nmol each) were 
chromatographed at 25 ·C on a Vydac Cts analytical column. The 
peptides were eluted using 0.1 % trifluoroacetic acid as solvent, apply-
ing a linear gradient from 9-28% (v/v) acetonitrile at a flow rate of 1 
ml/min. 
Procedures." The synthetic material was compared to natural 
w-conotoxin GVIA. Protein sequencing of the synthetic ma-
terial yielded the expected sequence, shown in Fig. 1. No 
significant "preview" of amino acids was observed, setting an 
upper limit of 1 % on contamination by shortened peptides 
arising from incomplete reactions in synthesis. The synthetic 
toxin was analyzed by reverse phase HPLC using two different 
solvent systems. The results in the trifluoroacetic acid system 
are shown in Fig. 2. In all cases, the elution times of the 
synthetic material were identical to those of authentic natural 
toxin, and a single sharp peak was seen in both chromato-
graphic systems upon mixing synthetic and natural toxins. 
Biological activity of the synthetic material was compared 
to natural toxin as described under "Experimental Proce-
dures." By these tests, synthetic and natural material were 
indistinguishable. Both elicited "shaker" symptoms in mice 
at higher doses (>2 nmol/kg), and at lower doses (-1 nmol/ 
kg), tail test symptoms were elicited ("Experimental Proce-
dures"). For both synthetic and natural toxins, a characteristic 
posture with back legs spread was assumed after the toxin 
was injected. 
In addition, we have derivatized the synthetic toxin by 
iodination, and the iodinated derivatives ofthe synthetic toxin 
are identical in their elution times to iodinated derivatives of 
the natural toxin (results not shown). Thus, by all criteria 
applied, the synthetic material is identical to authentic natu-
ral toxin. 
Effect of w-Conotoxin GVIA on Chick Brain Synaptosomes-
Chick brain synaptosomes were prepared by standard meth-
ods ("Experimental Procedures"). The purified synaptosomal 
preparation was then tested for voltage-sensitive 45Ca uptake, 
and the effects of w-conotoxin and nitrendipine (a dihydro-
pyridine calcium channel antagonist) were evaluated. Results 
of three different experiments are shown in Table II. When 
45Ca was added with low K+ (5 mM), a low constant level of 
45Ca was taken up by the synaptosomal vesicles. However, 
when 45Ca was added in the presence of depolarizing concen-
trations of potassium (137 mM), 45Ca uptake was significantly 
higher. This depolarization-induced uptake was greatly re-
duced (>90% inhibition) by predepolarization. 
The depolarization-induced 45Ca uptake was inhibited by 
w-conotoxin (Table II). However, little or no inhibition was 
seen when nitrendipine, a dihydropyridine calcium channel 
inhibitor was added. The concentration dependence of w-
conotoxin effects is shown in Fig. 3. It is clear that w-
conotoxin is an effective inhibitor of 45Ca2+ uptake by chick 
brain synaptosomes even at nanomolar concentrations. Under 
the present experimental conditions, 50% inhibition is 
achieved at 10-8 M w-conotoxin, and almost total inhibition 
(>90%) is achieved at the highest concentration tested. In 
contrast, even at 10-4 M nitrendipine inhibition is marginal 
(see Table II, experiment 3). 
The observed 45Ca uptake could have occurred as a conse-
quence of processes other than entry through voltage-sensitive 
Ca channels: Na+-Ca2+ exchange is postulated to contribute 
significantly under certain conditions. We minimized non-
channel processes by monitoring short pulses (1 s) of 45Ca. If 
a longer uptake period (i.e. 2 min) is allowed, 45Ca uptake 
increases approximately 4-fold, but most uptake is not w-
conotoxin sensitive. Short pulses measure the "fast" compo-
nent of CaH uptake, generally attributed to voltage-sensitive 
Ca2+ channels; the "slow" component is primarily assigned to 
nonchannel processes (reviewed in Ref. 5). Another standard 
method used to minimize the latter is Na+ replacement by 
choline; we found that w-conotoxin inhibition of Ca uptake 
in choline medium still occurred (>60% inhibition of 45Ca 
uptake). 
The amount of voltage-dependent 45Ca taken up by synap-
tosomes varies considerably from one synaptosomal prepara-
tion to the next (Table II) . The functional voltage-sensitive 
calcium channels appear to have a half-life of only a few hours 
under the conditions being used (see Table III); in experiment 
2, Table III, -90% of voltage-dependent uptake was lost when 
the synaptosomal preparation was incubated in an ice bucket 
overnight. Variation in preparation times may partially ac-
TABLE II 
··Ca uptake measurements on chick brain synaptosomes 
45Ca uptake measurements were carried out on chick brain synap-
tosomes as described under "Experimental Procedures." The data 
points are average of three determinations with the standard devia-




Low K+, control 
High K+, control 
High K+, + nitrendipine (10 I'M) 
High K+, + w-conotoxin (13.3 I'M) 
Experiment 2 
Low K+, control 
High K+, control 
High K, + nitrendipine (10 I'M) 
High K, + w-conotoxin (13.3 I'M) 
Experiment 3 
Low K+, control 
High K+, control 
High K+, + nitrendipine (100 I'M) 
High K+, + w-conotoxin (13.3 I'M) 
Low K+, + w-conotoxin (13.3 I'M) 
cpm 
680 ± 120 
2340 ± 380 
2880±380 
820 ± 200 
270 ± 20 
1120 ± 150 
1170 ± 240 
470 ± 60 
920 ± 50 
6250 ± 1300 
5910 ± 690 
2020 ± 270 
930 ± 130 
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FIG. 3. Concentration dependence of w-conotoxin inhibition 
of nCa uptake by chick brain aynaptosomes .• 5ea uptake was 
measured as described under "Experimental Procedures." The syn-
aptosomes were preincubated with w-conotoxin at the concentrations 
indicated for 30 min before ,sea uptake was measured. In this exper-
iment, the actual values for ,sea uptake were: high K control, 6000 
cpm; low K control 1280 cpm. Thus, the difference between these two 
values, 4720 cpm was set as 100% of voltage activated .5ea uptake. 
Each experimental point for ,sea uptake in the presence of w-cono-
toxin with the low K control (1280 cpm) subtracted out is shown by 
the circles; the line is drawn to the average of these points at each w-
conotoxin concentration. 
TABLE III 
Dependence of "Ca uptake on age of preparation 
Experiments were carried out on two different synaptosomal prep-
arations. Time is measured from the time the chicks were killed. 
Experiment 1 
Experiment 2 
H after "Ca uptake 
dissec· -Lo-w- H- i-g-h- H-ig-h-K 




























count for the inconstancy of ... sCa uptake by different synap-
tosomal preparations, although other factors during synap-
tosome preparation may also influence 4SCa2+ uptake by the 
final preparation. However, w-conotoxin inhibition, and the 
lack of inhibition by dihydropyridines is seen reproducibly in 
all preparations. 
It should be noted that although w-conotoxin inhibitable 
4SCa uptake sites are labile (Table III), w-conotoxin-binding 
sites are stable (results not shown). Thus, while voltage-
activated calcium channels are rapidly inactivated in synap-
tosomal preparations, the results suggest that w-conotoxin 
can stilI bind the inactivated calcium channels. 
DISCUSSION 
Calcium channels are a central, indispensable component 
of neuronal function. At the present time, voltage-activated 
Ca channels are the only system known to transduce electrical 
signals into biochemical events: for an electrical signal to 
result in an intracellular change a rise in cytoplasmic calcium 
levels must first take place. However, despite their key role 
in neuronal function, little progress has been made in the 
biochemical characterization of such voltage-sensitive cal-
cium channels. The results described in this report establish 
that w-conotoxins are a useful probe for these important 
neuronal molecules. 
Calcium channels have been studied effectively in skeletal 
muscle and in cardiac tissue. The most commonly used agents 
for dissecting these channels in muscle are the dihydropyri-
dine drugs such as nitrendipine. Purification of voltage-sen-
sitive calcium channels from skeletal muscle T tubules was 
accomplished by using dihydropyridine binding as an assay 
(18, 19). However, the dihydropyridines have been relatively 
ineffective in studying calcium channels from neuronal tissue. 
In fact, there is increasing experimental evidence that calcium 
channels are probably different in neuronal and in muscle 
tissue, even though electrophysiologically similar calcium 
channel types may be found in both tissues (see for example 
Refs. 9 and 10). 
Electrophysiological and pharmacological evidence strongly 
indicates that several different calcium channel types exist in 
neuronal tissue. The most direct evidence has been provided 
by Tsien and co-workers (10),1 who have used single channel-
recording techniques to characterize three different calcium 
channel types from embryonic chick dorsal root ganglion cells 
in culture. These three calcium channel types, which have 
been termed L, T, and N channels, differ in their electro-
physiological characteristics, both with respect to their con-
ductance once the channel is open, and to their activation 
and inactivation characteristics (10). In addition, the channels 
can be distinguished pharmacologically: L channels are af-
fected by both the dihydropyridines and w-conotoxin; N chan-
nels are effectively inhibited by w-conotoxin but not by the 
dihydropyridines. The T channels are relatively resistant to 
inhibition by both the dihydropyridines and w-conotoxin; with 
the latter, only a transient inhibition is observed. l 
Although the level of analysis is far less sophisticated than 
the most advanced electrophysiological methods, the use of 
synaptosomal preparations allows bulk assays of ion channels. 
Most workers find that the majority of calcium currents in 
synaptosomes of neuronal origin appear to be refractory to 
dihydropyridine inhibition, a result we obtained in the chick 
brain preparation (for a review, see Ref. 5). Our results 
demonstrate that w-conotoxin is effective in abolishing volt-
age-activated 45Ca entry into chick brain synaptosomes. We 
conclude that in this synaptosome preparation, the voltage-
activated entry of 4SCa is mediated mainly by N -like channels, 
which are w-sensitive but dihydropyridine-insensitive. 
Whether these will prove to be identical to the N channels 
that have been described from embryonic chick dorsal root 
ganglion cells in culture (10) remains to be established. Since 
synaptosomes come primarily from nerve endings, the results 
suggest that N-type channels may be the predominant chan-
nel in the presynaptic termini of nerves. 
In addition to characterizing the nature of voltage-sensitive 
calcium channels in synaptosomes, the experiments described 
here provide a convenient assay both for w-conotoxin and 
active target channels. Previously, we described the binding 
of w-conotoxin to synaptosomal preparations. The present 
experiments provide a functional correlate to binding studies. 
The development of a relatively simple functional assay, and 
the availability of chemically synthesized w-conotoxin GVIA 
should significantly increase the potential of this peptide 
neurotoxin for the biochemical characterization of neuronal 
calcium channels. 
 at UNIV O










1198 Neuronal Ca 2+ Channels and w-Conotoxin 
Ackrwwledgments-FAB mass spectrometry was carried out by Dr. 
T. Lee, Beckman Research Institute of Tbe City of Hope, Duarte, 
CA. Assays and iodination experiments were performed by G. Corpuz, 
G. LeCheminant, D. Griffin, and D. Johnson. Amino acid analyses 
were carried out by J. Dykert and C. Ramilo. Equipment used in the 
Philippines was provided by the International Foundation for Sci-
ence, Stockholm, Sweden. 
REFERENCES 
1. Katz, B. (1969) The Release of Neural Transmitter Substances. 
Liverpool University Press, Liverpool 
2. Llinas, R., Steinberg, I. Z., and Walton, K. (1981) Biophys. J. 33, 
323-352 
3. Llinas, R., and Yarom, Y. (1981) J. Physiol. 315,569-584 
4. Janis, R. A., and Triggle, D. J. (1984) Drug Dev. Res. 4, 257-274 
5. Miller, R. J. (1986) Recept. Biochem. Methodol. 7, in press 
6. Olivera, B. M., McIntosh, J. M., Cruz, L. J., Luque, F. A., and 
Gray, W. R. (1984) Biochemistry 23, 5087-5090 
7. Olivera, B. M., McIntosh, J. M., Zeikus, R., Gray, W. R., Varga, 
J., Rivier, J., de Santos, V., and Cruz, L. J. (1985) Science 230, 
1338-1343 
8. Kerr, L. M., and Yoshikami, D. (1984) Nature 308, 282-284 
9. Cruz, L. J., Johnson, D. S., and Olivera, B. M. (1986) Biochem-
istry, in press 
10. Nowycky, M. C., Fox, A. P., and Tsien, R. W. (1985) Nature 
316,440-443 
11. Cruz, L. J., and Olivera, B. M. (1986) J. Bioi. Chem. 261,6230-
6233 
12. Rivier, J., Amoss, M., Rivier, C., and Vale, W. (1974) J. Med. 
Chem. 17, 230-233 
13. Marki, W., Spiess, J., Tache, Y., Brown, M., and Rivier, J. E. 
(1980) J. Am. Chem. Soc. 103,3178-3185 
14. Rivier, J., McClintock, R., Galyean, R., and Anderson, H. (1984) 
J. Chromatogr. 288, 303-328 
15. Veber, D., Milkowski, J., Varga, S., Denkewalter, R., and Hirsch-
mann, R. (1972) J. Am. Chem. Soc. 94, 5456-5461 
16. Krueger, B. K., Ratzlaff, R. W., 8trichartz, G. R., and Blaustein, 
M. P. (1979) J. Membr. Bioi. 50, 287-310 
17. Blaustein, M. P. (1975) J. Physiol. 247,617-655 
18. Curtis, B. M., and Catterall, W. A. (1984) Biochemistry 23,2113-
2118 
19. Borsotto, M., Norman, R. I., Fosset, M., and Lazdunski, M. (1984) 
Eur. J. Biochem. 142, 449-455 
20. Giossmann, H., Ferry, D. R., Goll, A., and Rombusch, M. (1984) 
J. Cardiovasc. Pharmacol. 6, S608-8621 
21. Deleted in proof 
22. Deleted in proof 
